MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Palliative and end-of-life care in Parkinson’s disease : French patients’ perceptions and knowledge

M. Auffret, L. Cronier, G. Robert, M. Béreau, M. Giffard, M. Vérin (Rennes, France)

Meeting: 2024 International Congress

Abstract Number: 622

Keywords: Parkinson’s

Category: Palliative Care

Objective: (1) Assess patients’ perceptions and knowledge of palliative and end-of-life care in PD; (2) evaluate (i) whether patients discuss these topics with healthcare professionals and/or their families, (ii) and whether they make use of existing French legal procedures (advance directives, trusted support person).

Background: Palliative care is receiving a growing interest in Parkinson’ disease (PD). However, few studies have examined the perceptions and knowledge of Parkinson’s patients Parkinson’s disease on palliative and end-of-life care. A better understanding of patients’perspective is critical to identify levers for action and improve patients’ access to palliative care resources, A small study led by our group last year on 60 French PD patients highlighted a practice gap.

Method: Anonymous online questionnaire (March to June 2023), with the survey link sent by email to participants through French PD patients’ associations and healthcare professionals (neurologists & home healthcare provider nurses)

Results: 200 patients (48% female, mean age 70 years old) responded to the survey. Most patients did not consider themselves well informed about palliative care (62,5%). They never discussed palliative care with their medical team (85%) nor with their family (55.5%), even though they felt they can benefit from palliative care palliative care because of their illness (86.5%). Most patients had already thought about about the end of life (EOL, 74.5%) and find it frightening (61.5%).

They never discuss about EOL with their medical team (72.5%), but do have end-of-life discussions with their family (66%). They have never received any documentation from professionals (94.5%). 70% of patients are aware of the existence of an end-of-life law. Only a small number of patients have designated a trusted support person (56%) or written up their advance directives (31%), even though they are unanimously convinced of the value of both of these legal procedures (96%).

Conclusion: French PD patients are not properly informed about palliative care. 

Neurology teams need to invest in this area in order to meet patients’ needs

To cite this abstract in AMA style:

M. Auffret, L. Cronier, G. Robert, M. Béreau, M. Giffard, M. Vérin. Palliative and end-of-life care in Parkinson’s disease : French patients’ perceptions and knowledge [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/palliative-and-end-of-life-care-in-parkinsons-disease-french-patients-perceptions-and-knowledge/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/palliative-and-end-of-life-care-in-parkinsons-disease-french-patients-perceptions-and-knowledge/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley